A Single-dose Study to Investigate the Tolerance and Pharmacokinetics of Finamine Tablets in China

NCT04162275 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Finamine tablets
DRUG: Placebo tablets

Sponsor

Yiling Pharmaceutical Inc.